nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—TACR3—iris—glaucoma	0.111	0.972	CbGeAlD
Aprepitant—CYP1A2—Betaxolol—glaucoma	0.0583	0.117	CbGbCtD
Aprepitant—CYP2C19—Methazolamide—glaucoma	0.0479	0.0962	CbGbCtD
Aprepitant—CYP2C9—Diclofenamide—glaucoma	0.0462	0.0929	CbGbCtD
Aprepitant—CYP2C9—Dorzolamide—glaucoma	0.0447	0.0897	CbGbCtD
Aprepitant—CYP3A5—Clonidine—glaucoma	0.0429	0.0862	CbGbCtD
Aprepitant—CYP2C19—Timolol—glaucoma	0.0407	0.0818	CbGbCtD
Aprepitant—CYP2C9—Methazolamide—glaucoma	0.0398	0.0799	CbGbCtD
Aprepitant—CYP3A4—Pilocarpine—glaucoma	0.0343	0.0688	CbGbCtD
Aprepitant—CYP1A2—Clonidine—glaucoma	0.0319	0.0641	CbGbCtD
Aprepitant—CYP3A4—Brinzolamide—glaucoma	0.0269	0.054	CbGbCtD
Aprepitant—CYP3A4—Dorzolamide—glaucoma	0.026	0.0522	CbGbCtD
Aprepitant—CYP3A4—Methazolamide—glaucoma	0.0231	0.0465	CbGbCtD
Aprepitant—CYP3A4—Acetazolamide—glaucoma	0.0185	0.0372	CbGbCtD
Aprepitant—CYP3A4—Clonidine—glaucoma	0.0167	0.0336	CbGbCtD
Aprepitant—TACR1—connective tissue—glaucoma	0.00316	0.0277	CbGeAlD
Aprepitant—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000262	0.00407	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—OPN4—glaucoma	0.000256	0.00398	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—C3—glaucoma	0.000255	0.00397	CbGpPWpGaD
Aprepitant—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000254	0.00395	CbGpPWpGaD
Aprepitant—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000254	0.00395	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—PTGFR—glaucoma	0.000254	0.00395	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—PTGS2—glaucoma	0.000238	0.00371	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—SMO—glaucoma	0.000238	0.0037	CbGpPWpGaD
Aprepitant—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000236	0.00367	CbGpPWpGaD
Aprepitant—CYP3A5—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000233	0.00362	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—PTGFR—glaucoma	0.00023	0.00358	CbGpPWpGaD
Aprepitant—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.00023	0.00357	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—SMO—glaucoma	0.000226	0.00352	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—CDKN1B—glaucoma	0.000226	0.00351	CbGpPWpGaD
Aprepitant—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000224	0.00348	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—LRP12—glaucoma	0.000218	0.00339	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—RPTOR—glaucoma	0.000218	0.00339	CbGpPWpGaD
Aprepitant—CYP2C19—Melatonin metabolism and effects—APOE—glaucoma	0.000215	0.00334	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—NCK2—glaucoma	0.000211	0.00329	CbGpPWpGaD
Aprepitant—CYP2C19—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000211	0.00328	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—MMP9—glaucoma	0.000209	0.00325	CbGpPWpGaD
Aprepitant—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	0.000206	0.0032	CbGpPWpGaD
Aprepitant—Diarrhoea—Apraclonidine—glaucoma	0.000205	0.000633	CcSEcCtD
Aprepitant—Malaise—Clonidine—glaucoma	0.000205	0.000632	CcSEcCtD
Aprepitant—Mediastinal disorder—Betaxolol—glaucoma	0.000204	0.000632	CcSEcCtD
Aprepitant—Dyspepsia—Pilocarpine—glaucoma	0.000204	0.000631	CcSEcCtD
Aprepitant—Chills—Betaxolol—glaucoma	0.000204	0.000629	CcSEcCtD
Aprepitant—Syncope—Clonidine—glaucoma	0.000203	0.000629	CcSEcCtD
Aprepitant—Feeling abnormal—Dorzolamide—glaucoma	0.000202	0.000625	CcSEcCtD
Aprepitant—Decreased appetite—Pilocarpine—glaucoma	0.000202	0.000623	CcSEcCtD
Aprepitant—Feeling abnormal—Travoprost—glaucoma	0.000201	0.000622	CcSEcCtD
Aprepitant—Conjunctivitis—Timolol—glaucoma	0.000201	0.00062	CcSEcCtD
Aprepitant—Gastrointestinal pain—Dorzolamide—glaucoma	0.000201	0.00062	CcSEcCtD
Aprepitant—Alopecia—Betaxolol—glaucoma	0.000201	0.00062	CcSEcCtD
Aprepitant—Palpitations—Clonidine—glaucoma	0.0002	0.00062	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Pilocarpine—glaucoma	0.0002	0.000619	CcSEcCtD
Aprepitant—Gastrointestinal pain—Travoprost—glaucoma	0.0002	0.000617	CcSEcCtD
Aprepitant—Loss of consciousness—Clonidine—glaucoma	0.000199	0.000616	CcSEcCtD
Aprepitant—Feeling abnormal—Brinzolamide—glaucoma	0.000199	0.000614	CcSEcCtD
Aprepitant—Mental disorder—Betaxolol—glaucoma	0.000199	0.000614	CcSEcCtD
Aprepitant—Pain—Pilocarpine—glaucoma	0.000198	0.000613	CcSEcCtD
Aprepitant—Constipation—Pilocarpine—glaucoma	0.000198	0.000613	CcSEcCtD
Aprepitant—Cough—Clonidine—glaucoma	0.000198	0.000612	CcSEcCtD
Aprepitant—Dizziness—Apraclonidine—glaucoma	0.000198	0.000612	CcSEcCtD
Aprepitant—Erythema—Betaxolol—glaucoma	0.000198	0.00061	CcSEcCtD
Aprepitant—Malnutrition—Betaxolol—glaucoma	0.000198	0.00061	CcSEcCtD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000196	0.00305	CbGpPWpGaD
Aprepitant—Urticaria—Dorzolamide—glaucoma	0.000195	0.000602	CcSEcCtD
Aprepitant—Abdominal pain—Dorzolamide—glaucoma	0.000194	0.000599	CcSEcCtD
Aprepitant—Body temperature increased—Dorzolamide—glaucoma	0.000194	0.000599	CcSEcCtD
Aprepitant—Dysgeusia—Betaxolol—glaucoma	0.000193	0.000598	CcSEcCtD
Aprepitant—Chest pain—Clonidine—glaucoma	0.000193	0.000597	CcSEcCtD
Aprepitant—Arthralgia—Clonidine—glaucoma	0.000193	0.000597	CcSEcCtD
Aprepitant—Abdominal pain—Travoprost—glaucoma	0.000193	0.000597	CcSEcCtD
Aprepitant—Anxiety—Clonidine—glaucoma	0.000192	0.000595	CcSEcCtD
Aprepitant—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000192	0.00299	CbGpPWpGaD
Aprepitant—Asthenia—Acetazolamide—glaucoma	0.000192	0.000594	CcSEcCtD
Aprepitant—Dizziness—Bimatoprost—glaucoma	0.000192	0.000593	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000192	0.000593	CcSEcCtD
Aprepitant—Urticaria—Brinzolamide—glaucoma	0.000192	0.000592	CcSEcCtD
Aprepitant—CYP3A5—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000191	0.00297	CbGpPWpGaD
Aprepitant—Feeling abnormal—Pilocarpine—glaucoma	0.000191	0.00059	CcSEcCtD
Aprepitant—Discomfort—Clonidine—glaucoma	0.000191	0.00059	CcSEcCtD
Aprepitant—Vomiting—Apraclonidine—glaucoma	0.00019	0.000588	CcSEcCtD
Aprepitant—Muscle spasms—Betaxolol—glaucoma	0.00019	0.000587	CcSEcCtD
Aprepitant—Gastrointestinal pain—Pilocarpine—glaucoma	0.00019	0.000586	CcSEcCtD
Aprepitant—Hypersensitivity—Brimonidine—glaucoma	0.000189	0.000585	CcSEcCtD
Aprepitant—Dry mouth—Clonidine—glaucoma	0.000189	0.000584	CcSEcCtD
Aprepitant—Bradycardia—Timolol—glaucoma	0.000189	0.000583	CcSEcCtD
Aprepitant—Dermatitis—Apraclonidine—glaucoma	0.000189	0.000583	CcSEcCtD
Aprepitant—Headache—Apraclonidine—glaucoma	0.000187	0.000579	CcSEcCtD
Aprepitant—Confusional state—Clonidine—glaucoma	0.000187	0.000577	CcSEcCtD
Aprepitant—Oedema—Clonidine—glaucoma	0.000185	0.000572	CcSEcCtD
Aprepitant—Tremor—Betaxolol—glaucoma	0.000185	0.000572	CcSEcCtD
Aprepitant—Hallucination—Timolol—glaucoma	0.000184	0.00057	CcSEcCtD
Aprepitant—Asthenia—Brimonidine—glaucoma	0.000184	0.00057	CcSEcCtD
Aprepitant—Infection—Clonidine—glaucoma	0.000184	0.000568	CcSEcCtD
Aprepitant—Abdominal pain—Pilocarpine—glaucoma	0.000183	0.000566	CcSEcCtD
Aprepitant—Body temperature increased—Pilocarpine—glaucoma	0.000183	0.000566	CcSEcCtD
Aprepitant—Ill-defined disorder—Betaxolol—glaucoma	0.000183	0.000566	CcSEcCtD
Aprepitant—Diarrhoea—Acetazolamide—glaucoma	0.000183	0.000566	CcSEcCtD
Aprepitant—Rash—Bimatoprost—glaucoma	0.000183	0.000565	CcSEcCtD
Aprepitant—Dermatitis—Bimatoprost—glaucoma	0.000183	0.000565	CcSEcCtD
Aprepitant—Anaemia—Betaxolol—glaucoma	0.000183	0.000564	CcSEcCtD
Aprepitant—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000182	0.00284	CbGpPWpGaD
Aprepitant—Shock—Clonidine—glaucoma	0.000182	0.000563	CcSEcCtD
Aprepitant—Connective tissue disorder—Timolol—glaucoma	0.000182	0.000563	CcSEcCtD
Aprepitant—Pruritus—Brimonidine—glaucoma	0.000182	0.000562	CcSEcCtD
Aprepitant—Headache—Bimatoprost—glaucoma	0.000182	0.000562	CcSEcCtD
Aprepitant—Nervous system disorder—Clonidine—glaucoma	0.000182	0.000561	CcSEcCtD
Aprepitant—Thrombocytopenia—Clonidine—glaucoma	0.000181	0.00056	CcSEcCtD
Aprepitant—Hypersensitivity—Dorzolamide—glaucoma	0.000181	0.000559	CcSEcCtD
Aprepitant—Tachycardia—Clonidine—glaucoma	0.000181	0.000558	CcSEcCtD
Aprepitant—Hypersensitivity—Travoprost—glaucoma	0.00018	0.000556	CcSEcCtD
Aprepitant—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.00018	0.0028	CbGpPWpGaD
Aprepitant—Skin disorder—Clonidine—glaucoma	0.00018	0.000556	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—HDAC9—glaucoma	0.00018	0.00279	CbGpPWpGaD
Aprepitant—Hyperhidrosis—Clonidine—glaucoma	0.000179	0.000553	CcSEcCtD
Aprepitant—Malaise—Betaxolol—glaucoma	0.000178	0.00055	CcSEcCtD
Aprepitant—Nausea—Apraclonidine—glaucoma	0.000178	0.000549	CcSEcCtD
Aprepitant—Hypersensitivity—Brinzolamide—glaucoma	0.000178	0.000549	CcSEcCtD
Aprepitant—Syncope—Betaxolol—glaucoma	0.000177	0.000547	CcSEcCtD
Aprepitant—Dizziness—Acetazolamide—glaucoma	0.000177	0.000547	CcSEcCtD
Aprepitant—Anorexia—Clonidine—glaucoma	0.000177	0.000545	CcSEcCtD
Aprepitant—CYP3A7—Biological oxidations—GSTT1—glaucoma	0.000176	0.00274	CbGpPWpGaD
Aprepitant—Asthenia—Dorzolamide—glaucoma	0.000176	0.000544	CcSEcCtD
Aprepitant—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	0.000176	0.00273	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.000176	0.00273	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000176	0.00273	CbGpPWpGaD
Aprepitant—Asthenia—Travoprost—glaucoma	0.000175	0.000542	CcSEcCtD
Aprepitant—Palpitations—Betaxolol—glaucoma	0.000175	0.000539	CcSEcCtD
Aprepitant—Pruritus—Dorzolamide—glaucoma	0.000174	0.000536	CcSEcCtD
Aprepitant—Loss of consciousness—Betaxolol—glaucoma	0.000174	0.000536	CcSEcCtD
Aprepitant—Eye disorder—Timolol—glaucoma	0.000173	0.000535	CcSEcCtD
Aprepitant—Asthenia—Brinzolamide—glaucoma	0.000173	0.000535	CcSEcCtD
Aprepitant—Hypotension—Clonidine—glaucoma	0.000173	0.000535	CcSEcCtD
Aprepitant—Pruritus—Travoprost—glaucoma	0.000173	0.000534	CcSEcCtD
Aprepitant—Tinnitus—Timolol—glaucoma	0.000173	0.000534	CcSEcCtD
Aprepitant—TACR3—GPCR downstream signaling—EDN1—glaucoma	0.000173	0.00269	CbGpPWpGaD
Aprepitant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000173	0.00269	CbGpPWpGaD
Aprepitant—Cough—Betaxolol—glaucoma	0.000172	0.000533	CcSEcCtD
Aprepitant—Nausea—Bimatoprost—glaucoma	0.000172	0.000533	CcSEcCtD
Aprepitant—Cardiac disorder—Timolol—glaucoma	0.000172	0.000532	CcSEcCtD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000171	0.00266	CbGpPWpGaD
Aprepitant—Hypersensitivity—Pilocarpine—glaucoma	0.000171	0.000528	CcSEcCtD
Aprepitant—Pruritus—Brinzolamide—glaucoma	0.000171	0.000527	CcSEcCtD
Aprepitant—Vomiting—Acetazolamide—glaucoma	0.00017	0.000526	CcSEcCtD
Aprepitant—Dizziness—Brimonidine—glaucoma	0.00017	0.000525	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Clonidine—glaucoma	0.000169	0.000521	CcSEcCtD
Aprepitant—Angiopathy—Timolol—glaucoma	0.000168	0.00052	CcSEcCtD
Aprepitant—Arthralgia—Betaxolol—glaucoma	0.000168	0.00052	CcSEcCtD
Aprepitant—Chest pain—Betaxolol—glaucoma	0.000168	0.00052	CcSEcCtD
Aprepitant—Myalgia—Betaxolol—glaucoma	0.000168	0.00052	CcSEcCtD
Aprepitant—Diarrhoea—Dorzolamide—glaucoma	0.000168	0.000519	CcSEcCtD
Aprepitant—Headache—Acetazolamide—glaucoma	0.000168	0.000518	CcSEcCtD
Aprepitant—Anxiety—Betaxolol—glaucoma	0.000168	0.000518	CcSEcCtD
Aprepitant—Insomnia—Clonidine—glaucoma	0.000167	0.000518	CcSEcCtD
Aprepitant—Immune system disorder—Timolol—glaucoma	0.000167	0.000517	CcSEcCtD
Aprepitant—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	0.000167	0.0026	CbGpPWpGaD
Aprepitant—Diarrhoea—Travoprost—glaucoma	0.000167	0.000517	CcSEcCtD
Aprepitant—Mediastinal disorder—Timolol—glaucoma	0.000167	0.000516	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000167	0.000516	CcSEcCtD
Aprepitant—Asthenia—Pilocarpine—glaucoma	0.000166	0.000514	CcSEcCtD
Aprepitant—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000166	0.00259	CbGpPWpGaD
Aprepitant—Paraesthesia—Clonidine—glaucoma	0.000166	0.000514	CcSEcCtD
Aprepitant—Discomfort—Betaxolol—glaucoma	0.000166	0.000513	CcSEcCtD
Aprepitant—Dyspnoea—Clonidine—glaucoma	0.000165	0.00051	CcSEcCtD
Aprepitant—Diarrhoea—Brinzolamide—glaucoma	0.000165	0.00051	CcSEcCtD
Aprepitant—Somnolence—Clonidine—glaucoma	0.000165	0.000509	CcSEcCtD
Aprepitant—Dry mouth—Betaxolol—glaucoma	0.000164	0.000508	CcSEcCtD
Aprepitant—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000164	0.00256	CbGpPWpGaD
Aprepitant—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000164	0.00255	CbGpPWpGaD
Aprepitant—Pruritus—Pilocarpine—glaucoma	0.000164	0.000507	CcSEcCtD
Aprepitant—Alopecia—Timolol—glaucoma	0.000164	0.000506	CcSEcCtD
Aprepitant—Confusional state—Betaxolol—glaucoma	0.000163	0.000502	CcSEcCtD
Aprepitant—Mental disorder—Timolol—glaucoma	0.000162	0.000502	CcSEcCtD
Aprepitant—Dizziness—Dorzolamide—glaucoma	0.000162	0.000501	CcSEcCtD
Aprepitant—Rash—Brimonidine—glaucoma	0.000162	0.000501	CcSEcCtD
Aprepitant—Dermatitis—Brimonidine—glaucoma	0.000162	0.0005	CcSEcCtD
Aprepitant—Dizziness—Travoprost—glaucoma	0.000162	0.000499	CcSEcCtD
Aprepitant—Malnutrition—Timolol—glaucoma	0.000161	0.000499	CcSEcCtD
Aprepitant—Erythema—Timolol—glaucoma	0.000161	0.000499	CcSEcCtD
Aprepitant—Oedema—Betaxolol—glaucoma	0.000161	0.000498	CcSEcCtD
Aprepitant—TACR1—Spinal Cord Injury—TNF—glaucoma	0.000161	0.0025	CbGpPWpGaD
Aprepitant—Headache—Brimonidine—glaucoma	0.000161	0.000497	CcSEcCtD
Aprepitant—Decreased appetite—Clonidine—glaucoma	0.000161	0.000497	CcSEcCtD
Aprepitant—Infection—Betaxolol—glaucoma	0.00016	0.000495	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Clonidine—glaucoma	0.00016	0.000494	CcSEcCtD
Aprepitant—Fatigue—Clonidine—glaucoma	0.00016	0.000493	CcSEcCtD
Aprepitant—Dizziness—Brinzolamide—glaucoma	0.00016	0.000493	CcSEcCtD
Aprepitant—Nausea—Acetazolamide—glaucoma	0.000159	0.000491	CcSEcCtD
Aprepitant—Diarrhoea—Pilocarpine—glaucoma	0.000159	0.00049	CcSEcCtD
Aprepitant—Shock—Betaxolol—glaucoma	0.000159	0.00049	CcSEcCtD
Aprepitant—Pain—Clonidine—glaucoma	0.000158	0.000489	CcSEcCtD
Aprepitant—Constipation—Clonidine—glaucoma	0.000158	0.000489	CcSEcCtD
Aprepitant—Nervous system disorder—Betaxolol—glaucoma	0.000158	0.000489	CcSEcCtD
Aprepitant—Dysgeusia—Timolol—glaucoma	0.000158	0.000488	CcSEcCtD
Aprepitant—Thrombocytopenia—Betaxolol—glaucoma	0.000158	0.000488	CcSEcCtD
Aprepitant—Tachycardia—Betaxolol—glaucoma	0.000157	0.000486	CcSEcCtD
Aprepitant—TACR3—Signaling by GPCR—EDN1—glaucoma	0.000157	0.00244	CbGpPWpGaD
Aprepitant—Skin disorder—Betaxolol—glaucoma	0.000157	0.000484	CcSEcCtD
Aprepitant—Vomiting—Dorzolamide—glaucoma	0.000156	0.000482	CcSEcCtD
Aprepitant—Hyperhidrosis—Betaxolol—glaucoma	0.000156	0.000482	CcSEcCtD
Aprepitant—Rash—Dorzolamide—glaucoma	0.000155	0.000478	CcSEcCtD
Aprepitant—Dermatitis—Dorzolamide—glaucoma	0.000155	0.000478	CcSEcCtD
Aprepitant—Rash—Travoprost—glaucoma	0.000154	0.000476	CcSEcCtD
Aprepitant—Dermatitis—Travoprost—glaucoma	0.000154	0.000476	CcSEcCtD
Aprepitant—Headache—Dorzolamide—glaucoma	0.000154	0.000475	CcSEcCtD
Aprepitant—Anorexia—Betaxolol—glaucoma	0.000154	0.000475	CcSEcCtD
Aprepitant—Vomiting—Brinzolamide—glaucoma	0.000153	0.000474	CcSEcCtD
Aprepitant—Dizziness—Pilocarpine—glaucoma	0.000153	0.000474	CcSEcCtD
Aprepitant—Headache—Travoprost—glaucoma	0.000153	0.000473	CcSEcCtD
Aprepitant—Nausea—Brimonidine—glaucoma	0.000153	0.000472	CcSEcCtD
Aprepitant—Feeling abnormal—Clonidine—glaucoma	0.000153	0.000472	CcSEcCtD
Aprepitant—Rash—Brinzolamide—glaucoma	0.000152	0.00047	CcSEcCtD
Aprepitant—Dermatitis—Brinzolamide—glaucoma	0.000152	0.00047	CcSEcCtD
Aprepitant—Gastrointestinal pain—Clonidine—glaucoma	0.000151	0.000468	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—OPN4—glaucoma	0.000151	0.00235	CbGpPWpGaD
Aprepitant—Headache—Brinzolamide—glaucoma	0.000151	0.000467	CcSEcCtD
Aprepitant—TACR3—GPCR downstream signaling—C3—glaucoma	0.000151	0.00235	CbGpPWpGaD
Aprepitant—Hypotension—Betaxolol—glaucoma	0.000151	0.000465	CcSEcCtD
Aprepitant—TACR1—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.00015	0.00234	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—EDN1—glaucoma	0.000149	0.00232	CbGpPWpGaD
Aprepitant—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000148	0.0023	CbGpPWpGaD
Aprepitant—Angioedema—Timolol—glaucoma	0.000147	0.000456	CcSEcCtD
Aprepitant—Vomiting—Pilocarpine—glaucoma	0.000147	0.000456	CcSEcCtD
Aprepitant—Urticaria—Clonidine—glaucoma	0.000147	0.000455	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000147	0.000454	CcSEcCtD
Aprepitant—Body temperature increased—Clonidine—glaucoma	0.000146	0.000452	CcSEcCtD
Aprepitant—Abdominal pain—Clonidine—glaucoma	0.000146	0.000452	CcSEcCtD
Aprepitant—Rash—Pilocarpine—glaucoma	0.000146	0.000452	CcSEcCtD
Aprepitant—Dermatitis—Pilocarpine—glaucoma	0.000146	0.000451	CcSEcCtD
Aprepitant—Insomnia—Betaxolol—glaucoma	0.000146	0.000451	CcSEcCtD
Aprepitant—Nausea—Dorzolamide—glaucoma	0.000146	0.00045	CcSEcCtD
Aprepitant—Headache—Pilocarpine—glaucoma	0.000145	0.000449	CcSEcCtD
Aprepitant—Nausea—Travoprost—glaucoma	0.000145	0.000448	CcSEcCtD
Aprepitant—Paraesthesia—Betaxolol—glaucoma	0.000145	0.000447	CcSEcCtD
Aprepitant—Syncope—Timolol—glaucoma	0.000145	0.000447	CcSEcCtD
Aprepitant—Dyspnoea—Betaxolol—glaucoma	0.000144	0.000444	CcSEcCtD
Aprepitant—Nausea—Brinzolamide—glaucoma	0.000143	0.000443	CcSEcCtD
Aprepitant—Palpitations—Timolol—glaucoma	0.000143	0.000441	CcSEcCtD
Aprepitant—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000142	0.00221	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—TP53—glaucoma	0.000142	0.00221	CbGpPWpGaD
Aprepitant—Dyspepsia—Betaxolol—glaucoma	0.000142	0.000439	CcSEcCtD
Aprepitant—Loss of consciousness—Timolol—glaucoma	0.000142	0.000438	CcSEcCtD
Aprepitant—Cough—Timolol—glaucoma	0.000141	0.000435	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—HEYL—glaucoma	0.000141	0.00219	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—SMO—glaucoma	0.000141	0.00219	CbGpPWpGaD
Aprepitant—CYP3A7—Biological oxidations—CYP1B1—glaucoma	0.000141	0.00218	CbGpPWpGaD
Aprepitant—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.00014	0.00218	CbGpPWpGaD
Aprepitant—Decreased appetite—Betaxolol—glaucoma	0.00014	0.000433	CcSEcCtD
Aprepitant—Hypertension—Timolol—glaucoma	0.000139	0.000431	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Betaxolol—glaucoma	0.000139	0.00043	CcSEcCtD
Aprepitant—Fatigue—Betaxolol—glaucoma	0.000139	0.000429	CcSEcCtD
Aprepitant—CYP3A7—Metapathway biotransformation—CYP1B1—glaucoma	0.000139	0.00215	CbGpPWpGaD
Aprepitant—Constipation—Betaxolol—glaucoma	0.000138	0.000426	CcSEcCtD
Aprepitant—Pain—Betaxolol—glaucoma	0.000138	0.000426	CcSEcCtD
Aprepitant—Nausea—Pilocarpine—glaucoma	0.000138	0.000426	CcSEcCtD
Aprepitant—Myalgia—Timolol—glaucoma	0.000137	0.000425	CcSEcCtD
Aprepitant—Chest pain—Timolol—glaucoma	0.000137	0.000425	CcSEcCtD
Aprepitant—Arthralgia—Timolol—glaucoma	0.000137	0.000425	CcSEcCtD
Aprepitant—TACR3—Signaling by GPCR—C3—glaucoma	0.000137	0.00213	CbGpPWpGaD
Aprepitant—Anxiety—Timolol—glaucoma	0.000137	0.000423	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000136	0.000422	CcSEcCtD
Aprepitant—Hypersensitivity—Clonidine—glaucoma	0.000136	0.000422	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—PTGFR—glaucoma	0.000136	0.00212	CbGpPWpGaD
Aprepitant—Discomfort—Timolol—glaucoma	0.000136	0.000419	CcSEcCtD
Aprepitant—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000136	0.00211	CbGpPWpGaD
Aprepitant—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000135	0.0021	CbGpPWpGaD
Aprepitant—Dry mouth—Timolol—glaucoma	0.000134	0.000415	CcSEcCtD
Aprepitant—Asthenia—Clonidine—glaucoma	0.000133	0.000411	CcSEcCtD
Aprepitant—Feeling abnormal—Betaxolol—glaucoma	0.000133	0.000411	CcSEcCtD
Aprepitant—Confusional state—Timolol—glaucoma	0.000133	0.00041	CcSEcCtD
Aprepitant—Oedema—Timolol—glaucoma	0.000132	0.000407	CcSEcCtD
Aprepitant—Anaphylactic shock—Timolol—glaucoma	0.000132	0.000407	CcSEcCtD
Aprepitant—CYP1A2—Phase II conjugation—GSTT1—glaucoma	0.000131	0.00204	CbGpPWpGaD
Aprepitant—Pruritus—Clonidine—glaucoma	0.000131	0.000405	CcSEcCtD
Aprepitant—Infection—Timolol—glaucoma	0.000131	0.000404	CcSEcCtD
Aprepitant—TACR1—GPCR ligand binding—C3—glaucoma	0.00013	0.00203	CbGpPWpGaD
Aprepitant—Shock—Timolol—glaucoma	0.00013	0.0004	CcSEcCtD
Aprepitant—Nervous system disorder—Timolol—glaucoma	0.000129	0.000399	CcSEcCtD
Aprepitant—TACR1—SIDS Susceptibility Pathways—TNF—glaucoma	0.000129	0.002	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—NTRK2—glaucoma	0.000129	0.002	CbGpPWpGaD
Aprepitant—Urticaria—Betaxolol—glaucoma	0.000128	0.000396	CcSEcCtD
Aprepitant—Skin disorder—Timolol—glaucoma	0.000128	0.000395	CcSEcCtD
Aprepitant—CYP3A5—Biological oxidations—GSTT1—glaucoma	0.000127	0.00198	CbGpPWpGaD
Aprepitant—Body temperature increased—Betaxolol—glaucoma	0.000127	0.000394	CcSEcCtD
Aprepitant—Hyperhidrosis—Timolol—glaucoma	0.000127	0.000393	CcSEcCtD
Aprepitant—Diarrhoea—Clonidine—glaucoma	0.000127	0.000392	CcSEcCtD
Aprepitant—Anorexia—Timolol—glaucoma	0.000126	0.000388	CcSEcCtD
Aprepitant—CYP3A7—Metabolism—CA5A—glaucoma	0.000124	0.00192	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—NARFL—glaucoma	0.000124	0.00192	CbGpPWpGaD
Aprepitant—Hypotension—Timolol—glaucoma	0.000123	0.00038	CcSEcCtD
Aprepitant—Dizziness—Clonidine—glaucoma	0.000122	0.000378	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Timolol—glaucoma	0.00012	0.000371	CcSEcCtD
Aprepitant—Insomnia—Timolol—glaucoma	0.000119	0.000368	CcSEcCtD
Aprepitant—Hypersensitivity—Betaxolol—glaucoma	0.000119	0.000367	CcSEcCtD
Aprepitant—Paraesthesia—Timolol—glaucoma	0.000118	0.000365	CcSEcCtD
Aprepitant—Vomiting—Clonidine—glaucoma	0.000118	0.000364	CcSEcCtD
Aprepitant—Dyspnoea—Timolol—glaucoma	0.000117	0.000363	CcSEcCtD
Aprepitant—Somnolence—Timolol—glaucoma	0.000117	0.000362	CcSEcCtD
Aprepitant—Rash—Clonidine—glaucoma	0.000117	0.000361	CcSEcCtD
Aprepitant—Dermatitis—Clonidine—glaucoma	0.000117	0.00036	CcSEcCtD
Aprepitant—TACR1—Signaling by GPCR—SMO—glaucoma	0.000116	0.00181	CbGpPWpGaD
Aprepitant—Headache—Clonidine—glaucoma	0.000116	0.000358	CcSEcCtD
Aprepitant—Dyspepsia—Timolol—glaucoma	0.000116	0.000358	CcSEcCtD
Aprepitant—Asthenia—Betaxolol—glaucoma	0.000116	0.000357	CcSEcCtD
Aprepitant—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000115	0.00179	CbGpPWpGaD
Aprepitant—Decreased appetite—Timolol—glaucoma	0.000114	0.000354	CcSEcCtD
Aprepitant—Pruritus—Betaxolol—glaucoma	0.000114	0.000352	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Timolol—glaucoma	0.000114	0.000351	CcSEcCtD
Aprepitant—Fatigue—Timolol—glaucoma	0.000114	0.000351	CcSEcCtD
Aprepitant—Pain—Timolol—glaucoma	0.000113	0.000348	CcSEcCtD
Aprepitant—CYP3A7—Biological oxidations—GSTM1—glaucoma	0.000112	0.00175	CbGpPWpGaD
Aprepitant—CYP3A7—Metapathway biotransformation—GSTM1—glaucoma	0.000111	0.00172	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—NGFR—glaucoma	0.00011	0.00172	CbGpPWpGaD
Aprepitant—Diarrhoea—Betaxolol—glaucoma	0.00011	0.000341	CcSEcCtD
Aprepitant—Nausea—Clonidine—glaucoma	0.00011	0.00034	CcSEcCtD
Aprepitant—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.00011	0.0017	CbGpPWpGaD
Aprepitant—Feeling abnormal—Timolol—glaucoma	0.000109	0.000335	CcSEcCtD
Aprepitant—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000108	0.00168	CbGpPWpGaD
Aprepitant—Gastrointestinal pain—Timolol—glaucoma	0.000108	0.000333	CcSEcCtD
Aprepitant—Dizziness—Betaxolol—glaucoma	0.000107	0.000329	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—RPTOR—glaucoma	0.000107	0.00166	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—NTRK1—glaucoma	0.000105	0.00163	CbGpPWpGaD
Aprepitant—Urticaria—Timolol—glaucoma	0.000105	0.000323	CcSEcCtD
Aprepitant—Abdominal pain—Timolol—glaucoma	0.000104	0.000322	CcSEcCtD
Aprepitant—Body temperature increased—Timolol—glaucoma	0.000104	0.000322	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—NCK2—glaucoma	0.000103	0.0016	CbGpPWpGaD
Aprepitant—Vomiting—Betaxolol—glaucoma	0.000102	0.000317	CcSEcCtD
Aprepitant—Rash—Betaxolol—glaucoma	0.000102	0.000314	CcSEcCtD
Aprepitant—CYP3A5—Biological oxidations—CYP1B1—glaucoma	0.000102	0.00158	CbGpPWpGaD
Aprepitant—Dermatitis—Betaxolol—glaucoma	0.000102	0.000314	CcSEcCtD
Aprepitant—Headache—Betaxolol—glaucoma	0.000101	0.000312	CcSEcCtD
Aprepitant—CYP3A5—Metapathway biotransformation—CYP1B1—glaucoma	0.0001	0.00156	CbGpPWpGaD
Aprepitant—CYP2C19—Biological oxidations—GSTT1—glaucoma	9.86e-05	0.00153	CbGpPWpGaD
Aprepitant—Hypersensitivity—Timolol—glaucoma	9.7e-05	0.0003	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—CDKN2B—glaucoma	9.66e-05	0.0015	CbGpPWpGaD
Aprepitant—Nausea—Betaxolol—glaucoma	9.58e-05	0.000296	CcSEcCtD
Aprepitant—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	9.51e-05	0.00148	CbGpPWpGaD
Aprepitant—Asthenia—Timolol—glaucoma	9.45e-05	0.000292	CcSEcCtD
Aprepitant—Pruritus—Timolol—glaucoma	9.32e-05	0.000288	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—EDN1—glaucoma	9.27e-05	0.00144	CbGpPWpGaD
Aprepitant—Diarrhoea—Timolol—glaucoma	9.01e-05	0.000278	CcSEcCtD
Aprepitant—CYP2C9—Biological oxidations—GSTT1—glaucoma	8.99e-05	0.0014	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CA5A—glaucoma	8.93e-05	0.00139	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—NARFL—glaucoma	8.93e-05	0.00139	CbGpPWpGaD
Aprepitant—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	8.89e-05	0.00138	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—HDAC9—glaucoma	8.77e-05	0.00136	CbGpPWpGaD
Aprepitant—Dizziness—Timolol—glaucoma	8.71e-05	0.000269	CcSEcCtD
Aprepitant—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	8.67e-05	0.00135	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—NGF—glaucoma	8.52e-05	0.00132	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—EDN1—glaucoma	8.44e-05	0.00131	CbGpPWpGaD
Aprepitant—Vomiting—Timolol—glaucoma	8.37e-05	0.000259	CcSEcCtD
Aprepitant—CYP1A2—Phase II conjugation—GSTM1—glaucoma	8.36e-05	0.0013	CbGpPWpGaD
Aprepitant—Rash—Timolol—glaucoma	8.3e-05	0.000257	CcSEcCtD
Aprepitant—Dermatitis—Timolol—glaucoma	8.3e-05	0.000256	CcSEcCtD
Aprepitant—Headache—Timolol—glaucoma	8.25e-05	0.000255	CcSEcCtD
Aprepitant—CYP3A5—Biological oxidations—GSTM1—glaucoma	8.12e-05	0.00126	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—C3—glaucoma	8.1e-05	0.00126	CbGpPWpGaD
Aprepitant—CYP3A5—Metapathway biotransformation—GSTM1—glaucoma	8.01e-05	0.00125	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	7.92e-05	0.00123	CbGpPWpGaD
Aprepitant—CYP2C19—Biological oxidations—CYP1B1—glaucoma	7.85e-05	0.00122	CbGpPWpGaD
Aprepitant—Nausea—Timolol—glaucoma	7.82e-05	0.000242	CcSEcCtD
Aprepitant—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	7.74e-05	0.0012	CbGpPWpGaD
Aprepitant—CYP1A2—Biological oxidations—GSTT1—glaucoma	7.68e-05	0.00119	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—EDN1—glaucoma	7.66e-05	0.00119	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—APOE—glaucoma	7.54e-05	0.00117	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	7.5e-05	0.00117	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	7.5e-05	0.00117	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CAV1—glaucoma	7.47e-05	0.00116	CbGpPWpGaD
Aprepitant—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	7.41e-05	0.00115	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—C3—glaucoma	7.37e-05	0.00115	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	7.34e-05	0.00114	CbGpPWpGaD
Aprepitant—CYP2C9—Biological oxidations—CYP1B1—glaucoma	7.16e-05	0.00111	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—FN1—glaucoma	7.11e-05	0.00111	CbGpPWpGaD
Aprepitant—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	7.06e-05	0.0011	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—BAD—glaucoma	7.02e-05	0.00109	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—NARFL—glaucoma	6.91e-05	0.00107	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CA5A—glaucoma	6.91e-05	0.00107	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—SMO—glaucoma	6.87e-05	0.00107	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—C3—glaucoma	6.69e-05	0.00104	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	6.69e-05	0.00104	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CA5A—glaucoma	6.3e-05	0.000979	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—NARFL—glaucoma	6.3e-05	0.000979	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NTRK2—glaucoma	6.28e-05	0.000976	CbGpPWpGaD
Aprepitant—CYP2C19—Biological oxidations—GSTM1—glaucoma	6.28e-05	0.000976	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	6.24e-05	0.00097	CbGpPWpGaD
Aprepitant—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	6.19e-05	0.000963	CbGpPWpGaD
Aprepitant—CYP1A2—Biological oxidations—CYP1B1—glaucoma	6.12e-05	0.000951	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CA1—glaucoma	6.04e-05	0.000938	CbGpPWpGaD
Aprepitant—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	6.03e-05	0.000938	CbGpPWpGaD
Aprepitant—CYP3A4—Biological oxidations—GSTT1—glaucoma	5.93e-05	0.000921	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CTSA—glaucoma	5.85e-05	0.000909	CbGpPWpGaD
Aprepitant—CYP2C9—Biological oxidations—GSTM1—glaucoma	5.72e-05	0.00089	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	5.72e-05	0.000889	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—NOS3—glaucoma	5.65e-05	0.000878	CbGpPWpGaD
Aprepitant—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	5.65e-05	0.000878	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CA2—glaucoma	5.52e-05	0.000858	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NGFR—glaucoma	5.39e-05	0.000838	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CA5A—glaucoma	5.38e-05	0.000837	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—NARFL—glaucoma	5.38e-05	0.000837	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	5.35e-05	0.000831	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	5.35e-05	0.000831	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NTRK1—glaucoma	5.12e-05	0.000796	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CDKN1B—glaucoma	4.89e-05	0.000761	CbGpPWpGaD
Aprepitant—CYP1A2—Biological oxidations—GSTM1—glaucoma	4.89e-05	0.00076	CbGpPWpGaD
Aprepitant—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	4.82e-05	0.00075	CbGpPWpGaD
Aprepitant—CYP3A4—Biological oxidations—CYP1B1—glaucoma	4.72e-05	0.000734	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CDKN2B—glaucoma	4.72e-05	0.000733	CbGpPWpGaD
Aprepitant—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	4.66e-05	0.000724	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—MMP9—glaucoma	4.53e-05	0.000704	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—EDN1—glaucoma	4.53e-05	0.000704	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CA1—glaucoma	4.36e-05	0.000678	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CTSA—glaucoma	4.23e-05	0.000657	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NGF—glaucoma	4.16e-05	0.000647	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NARFL—glaucoma	4.15e-05	0.000646	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CA5A—glaucoma	4.15e-05	0.000646	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—VEGFA—glaucoma	4.07e-05	0.000633	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CA2—glaucoma	3.99e-05	0.00062	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—C3—glaucoma	3.95e-05	0.000615	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—TXN—glaucoma	3.89e-05	0.000605	CbGpPWpGaD
Aprepitant—CYP3A4—Biological oxidations—GSTM1—glaucoma	3.78e-05	0.000587	CbGpPWpGaD
Aprepitant—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	3.72e-05	0.000579	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—APOE—glaucoma	3.68e-05	0.000572	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CAV1—glaucoma	3.65e-05	0.000567	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—FN1—glaucoma	3.47e-05	0.00054	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—BAD—glaucoma	3.43e-05	0.000533	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CA1—glaucoma	3.37e-05	0.000524	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CTSA—glaucoma	3.27e-05	0.000508	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CA2—glaucoma	3.09e-05	0.00048	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CA1—glaucoma	3.08e-05	0.000478	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—TP53—glaucoma	3.07e-05	0.000478	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GSTT1—glaucoma	3.02e-05	0.000469	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.02e-05	0.000469	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.02e-05	0.000469	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CTSA—glaucoma	2.98e-05	0.000463	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CA2—glaucoma	2.81e-05	0.000437	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—TXN—glaucoma	2.81e-05	0.000437	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NOS3—glaucoma	2.76e-05	0.000429	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.75e-05	0.000427	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.75e-05	0.000427	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CA1—glaucoma	2.63e-05	0.000409	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CTSA—glaucoma	2.55e-05	0.000396	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CA2—glaucoma	2.4e-05	0.000374	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CYP1B1—glaucoma	2.4e-05	0.000374	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ABCA1—glaucoma	2.4e-05	0.000374	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CDKN1B—glaucoma	2.39e-05	0.000371	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.35e-05	0.000365	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.35e-05	0.000365	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MMP9—glaucoma	2.21e-05	0.000344	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GSTT1—glaucoma	2.18e-05	0.000339	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—TXN—glaucoma	2.17e-05	0.000338	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CA1—glaucoma	2.03e-05	0.000315	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—VEGFA—glaucoma	1.99e-05	0.000309	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.98e-05	0.000308	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—TXN—glaucoma	1.98e-05	0.000308	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.97e-05	0.000306	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CTSA—glaucoma	1.96e-05	0.000305	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GSTM1—glaucoma	1.92e-05	0.000299	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CA2—glaucoma	1.86e-05	0.000288	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.81e-05	0.000281	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.79e-05	0.000279	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CYP1B1—glaucoma	1.74e-05	0.00027	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ABCA1—glaucoma	1.74e-05	0.00027	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—MTHFR—glaucoma	1.7e-05	0.000264	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—TXN—glaucoma	1.69e-05	0.000263	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GSTT1—glaucoma	1.69e-05	0.000262	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—APOE—glaucoma	1.58e-05	0.000246	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CAV1—glaucoma	1.57e-05	0.000243	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.55e-05	0.00024	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GSTT1—glaucoma	1.54e-05	0.000239	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.53e-05	0.000238	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TP53—glaucoma	1.5e-05	0.000233	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GSTM1—glaucoma	1.39e-05	0.000216	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.36e-05	0.000211	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ABCA1—glaucoma	1.34e-05	0.000209	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYP1B1—glaucoma	1.34e-05	0.000209	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GSTT1—glaucoma	1.31e-05	0.000204	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—TXN—glaucoma	1.31e-05	0.000203	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.24e-05	0.000193	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—MTHFR—glaucoma	1.23e-05	0.000191	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ABCA1—glaucoma	1.22e-05	0.00019	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP1B1—glaucoma	1.22e-05	0.00019	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—NOS3—glaucoma	1.18e-05	0.000184	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—APOE—glaucoma	1.14e-05	0.000178	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CAV1—glaucoma	1.13e-05	0.000176	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PTGS2—glaucoma	1.08e-05	0.000168	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GSTM1—glaucoma	1.07e-05	0.000167	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.06e-05	0.000165	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP1B1—glaucoma	1.05e-05	0.000163	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ABCA1—glaucoma	1.05e-05	0.000163	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTT1—glaucoma	1.01e-05	0.000158	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GSTM1—glaucoma	9.79e-06	0.000152	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—MTHFR—glaucoma	9.49e-06	0.000148	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—APOE—glaucoma	8.83e-06	0.000137	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CAV1—glaucoma	8.75e-06	0.000136	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—MTHFR—glaucoma	8.65e-06	0.000134	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—NOS3—glaucoma	8.56e-06	0.000133	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GSTM1—glaucoma	8.37e-06	0.00013	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ABCA1—glaucoma	8.08e-06	0.000126	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP1B1—glaucoma	8.08e-06	0.000126	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—APOE—glaucoma	8.05e-06	0.000125	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CAV1—glaucoma	7.98e-06	0.000124	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PTGS2—glaucoma	7.83e-06	0.000122	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—MTHFR—glaucoma	7.39e-06	0.000115	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—APOE—glaucoma	6.88e-06	0.000107	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CAV1—glaucoma	6.82e-06	0.000106	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—NOS3—glaucoma	6.62e-06	0.000103	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTM1—glaucoma	6.46e-06	0.0001	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PTGS2—glaucoma	6.05e-06	9.41e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—NOS3—glaucoma	6.03e-06	9.38e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—MTHFR—glaucoma	5.71e-06	8.87e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PTGS2—glaucoma	5.52e-06	8.58e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—APOE—glaucoma	5.31e-06	8.26e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CAV1—glaucoma	5.26e-06	8.18e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—NOS3—glaucoma	5.16e-06	8.02e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PTGS2—glaucoma	4.72e-06	7.33e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NOS3—glaucoma	3.98e-06	6.19e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PTGS2—glaucoma	3.64e-06	5.66e-05	CbGpPWpGaD
